Panacea Biotec informs about updates

28 Oct 2023 Evaluate

Panacea Biotec has informed that about the launch of Paclitaxel Protein-Based Particles for Injectable Suspension (Albumin - Bound), a generic version of Abraxane in the Canadian market by its material wholly-owned subsidiary company viz. Panacea Biotec Pharma through its strategic partner Apotex Inc., Canada.

The above information is a part of company’s filings submitted to BSE.

Panacea Biotec Share Price

132.40 -2.25 (-1.67%)
30-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1466.00
Dr. Reddys Lab 5876.70
Cipla 1474.40
Zydus Lifesciences 1025.10
Lupin 1577.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.